Detailed TOC of Global Pertussis Vaccine Market Research Report 2026
1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Pertussis Vaccine Market Size
1.3 Market Segmentation
1.4 Regulatory Environment
2 Industry Chain Analysis
2.1 Industry Chain Analysis
2.2 Pertussis Vaccine Raw Materials Analysis
2.2.1 Key Raw Materials Introduction
2.2.2 Key Suppliers of Raw Materials
2.3 Pertussis Vaccine Business Mode and Production Process
2.3.1 Pertussis Vaccine Business Mode Analysis
2.3.2 Production Process Analysis
2.4 Pertussis Vaccine Cost Structure Analysis
2.4.1 Manufacturing Cost Structure of Pertussis Vaccine
2.4.2 Raw Material Cost of Pertussis Vaccine
2.4.3 Labor Cost of Pertussis Vaccine
2.5 Market Channel Analysis
2.6 Major Downstream Customers Analysis
2.7 Alternative Product Analysis
3 Market Dynamics
3.1 Market Drivers
3.2 Market Constraints and Challenges
3.3 Emerging Market Trends
3.4 PESTEL Analysis
3.5 Consumer Insights Analysis
3.6 Impact of Russia and Ukraine War
4 Market Competitive Landscape
4.1 Global Pertussis Vaccine Revenue and Market Share by Manufacturer (2021-2026)
4.2 Global Pertussis Vaccine Sales Volume and Market Share by Manufacturer (2021-2026)
4.3 Global Pertussis Vaccine Price by Manufacturer (2021-2026)
4.4 Pertussis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
4.5 Global Key Manufacturers of Pertussis Vaccine, Manufacturing Base Distribution and Headquarters
4.6 Global Key Manufacturers of Pertussis Vaccine, Product Offered and Application
4.7 Pertussis Vaccine Market Competitive Situation and Trends
4.7.1 Pertussis Vaccine Market Concentration Rate
4.7.2 Global Top 3 and Top 6 Pertussis Vaccine Players Market Share by Revenue
4.8 Industry News
4.8.1 Key Product Launch News
4.8.2 Mergers & Acquisitions, Expansion Plans
5 Global Pertussis Vaccine Market Historical Development by Geographic Region (2021-2026)
5.1 Global Pertussis Vaccine Market Historical Sales Volume by Geographic Region (2021-2026)
5.2 Global Pertussis Vaccine Market Historical Revenue by Geographic Region (2021-2026)
5.3 North America Pertussis Vaccine Market Status by Country (2021-2026)
5.3.1 North America Pertussis Vaccine Sales Volume by Country (2021-2026)
5.3.2 North America Pertussis Vaccine Revenue by Country (2021-2026)
5.3.3 United States Pertussis Vaccine Sales Volume, Revenue and Growth (2021-2026)
5.3.4 Canada Pertussis Vaccine Sales Volume, Revenue and Growth (2021-2026)
5.4 Europe Pertussis Vaccine Market Status by Country (2021-2026)
5.4.1 Europe Pertussis Vaccine Sales Volume by Country (2021-2026)
5.4.2 Europe Pertussis Vaccine Revenue by Country (2021-2026)
5.4.3 Germany Pertussis Vaccine Sales Volume, Revenue and Growth (2021-2026)
5.4.4 France Pertussis Vaccine Sales Volume, Revenue and Growth (2021-2026)
5.4.5 United Kingdom Pertussis Vaccine Sales Volume, Revenue and Growth (2021-2026)
5.4.6 Spain Pertussis Vaccine Sales Volume, Revenue and Growth (2021-2026)
5.4.7 Russia Pertussis Vaccine Sales Volume, Revenue and Growth (2021-2026)
5.4.8 Poland Pertussis Vaccine Sales Volume, Revenue and Growth (2021-2026)
5.5 Asia Pacific Pertussis Vaccine Market Status by Country (2021-2026)
5.5.1 Asia Pacific Pertussis Vaccine Sales Volume by Country (2021-2026)
5.5.2 Asia Pacific Pertussis Vaccine Revenue by Country (2021-2026)
5.5.3 China Pertussis Vaccine Sales Volume, Revenue and Growth (2021-2026)
5.5.4 Japan Pertussis Vaccine Sales Volume, Revenue and Growth (2021-2026)
5.5.5 South Korea Pertussis Vaccine Sales Volume, Revenue and Growth (2021-2026)
5.5.6 Southeast Asia Pertussis Vaccine Sales Volume, Revenue and Growth (2021-2026)
5.5.7 India Pertussis Vaccine Sales Volume, Revenue and Growth (2021-2026)
5.5.8 Australia Pertussis Vaccine Sales Volume, Revenue and Growth (2021-2026)
5.6 Latin America Pertussis Vaccine Market Status by Country (2021-2026)
5.6.1 Latin America Pertussis Vaccine Sales Volume by Country (2021-2026)
5.6.2 Latin America Pertussis Vaccine Revenue by Country (2021-2026)
5.6.3 Mexico Pertussis Vaccine Sales Volume, Revenue and Growth (2021-2026)
5.6.4 Brazil Pertussis Vaccine Sales Volume, Revenue and Growth (2021-2026)
5.7 Middle East and Africa Pertussis Vaccine Market Status by Country (2021-2026)
5.7.1 Middle East and Africa Pertussis Vaccine Sales Volume by Country (2021-2026)
5.7.2 Middle East and Africa Pertussis Vaccine Revenue by Country (2021-2026)
5.7.3 GCC Pertussis Vaccine Sales Volume, Revenue and Growth (2021-2026)
5.7.4 South Africa Pertussis Vaccine Sales Volume, Revenue and Growth (2021-2026)
6 Global Pertussis Vaccine Market Historical Development by Product Type (2021-2026)
6.1 Pertussis Vaccine Definition by Type
6.2 Global Pertussis Vaccine Historical Sales Volume by Product Type (2021-2026)
6.3 Global Pertussis Vaccine Historical Revenue by Product Type (2021-2026)
6.4 Global Pertussis Vaccine Historical Price by Product Type (2021-2026)
6.5 Global Historical Sales Volume, Revenue and Growth Rate by Product Type (2021-2026)
6.5.1 Global Pertussis Vaccine Historical Sales Volume, Revenue and Growth Rate of Acellular Vaccines (2021-2026)
6.5.2 Global Pertussis Vaccine Historical Sales Volume, Revenue and Growth Rate of Whole-cell Vaccines (2021-2026)
7 Global Pertussis Vaccine Market Historical Development by End User (2021-2026)
7.1 Downstream Market Overview
7.2 Global Pertussis Vaccine Historical Sales Volume by End User (2021-2026)
7.3 Global Pertussis Vaccine Historical Revenue by End User (2021-2026)
7.4 Global Pertussis Vaccine Historical Price by End User (2021-2026)
7.5 Global Historical Sales Volume, Revenue and Growth Rate by End User (2021-2026)
7.5.1 Global Pertussis Vaccine Historical Sales Volume, Revenue and Growth Rate of 12 Months Below (2021-2026)
7.5.2 Global Pertussis Vaccine Historical Sales Volume, Revenue and Growth Rate of 12 Months Above (2021-2026)
8 Leading Companies Profiles
8.1 GSK
8.1.1 GSK Corporation Information
8.1.2 GSK - Pertussis Vaccine Product Portfolio and Specification
8.1.3 GSK Performance Analysis (2021-2026)
8.1.4 GSK Business and Markets Served
8.1.5 GSK Recent Developments
8.2 Sanofi Pasteur
8.2.1 Sanofi Pasteur Corporation Information
8.2.2 Sanofi Pasteur - Pertussis Vaccine Product Portfolio and Specification
8.2.3 Sanofi Pasteur Performance Analysis (2021-2026)
8.2.4 Sanofi Pasteur Business and Markets Served
8.2.5 Sanofi Pasteur Recent Developments
8.3 Chengdu Institute of Biological Products
8.3.1 Chengdu Institute of Biological Products Corporation Information
8.3.2 Chengdu Institute of Biological Products - Pertussis Vaccine Product Portfolio and Specification
8.3.3 Chengdu Institute of Biological Products Performance Analysis (2021-2026)
8.3.4 Chengdu Institute of Biological Products Business and Markets Served
8.3.5 Chengdu Institute of Biological Products Recent Developments
8.4 Minhai Biotechnology
8.4.1 Minhai Biotechnology Corporation Information
8.4.2 Minhai Biotechnology - Pertussis Vaccine Product Portfolio and Specification
8.4.3 Minhai Biotechnology Performance Analysis (2021-2026)
8.4.4 Minhai Biotechnology Business and Markets Served
8.4.5 Minhai Biotechnology Recent Developments
8.5 KM Biologics
8.5.1 KM Biologics Corporation Information
8.5.2 KM Biologics - Pertussis Vaccine Product Portfolio and Specification
8.5.3 KM Biologics Performance Analysis (2021-2026)
8.5.4 KM Biologics Business and Markets Served
8.5.5 KM Biologics Recent Developments
8.6 Mitsubishi Tanabe Pharma
8.6.1 Mitsubishi Tanabe Pharma Corporation Information
8.6.2 Mitsubishi Tanabe Pharma - Pertussis Vaccine Product Portfolio and Specification
8.6.3 Mitsubishi Tanabe Pharma Performance Analysis (2021-2026)
8.6.4 Mitsubishi Tanabe Pharma Business and Markets Served
8.6.5 Mitsubishi Tanabe Pharma Recent Developments
8.7 Walvax Biotechnology
8.7.1 Walvax Biotechnology Corporation Information
8.7.2 Walvax Biotechnology - Pertussis Vaccine Product Portfolio and Specification
8.7.3 Walvax Biotechnology Performance Analysis (2021-2026)
8.7.4 Walvax Biotechnology Business and Markets Served
8.7.5 Walvax Biotechnology Recent Developments
8.8 Wuhan Institute of Biological Products
8.8.1 Wuhan Institute of Biological Products Corporation Information
8.8.2 Wuhan Institute of Biological Products - Pertussis Vaccine Product Portfolio and Specification
8.8.3 Wuhan Institute of Biological Products Performance Analysis (2021-2026)
8.8.4 Wuhan Institute of Biological Products Business and Markets Served
8.8.5 Wuhan Institute of Biological Products Recent Developments
9 Global Pertussis Vaccine Market Forecast by Product Type and End User (2026-2034)
9.1 Global Pertussis Vaccine Market Forecast by Product Type (2026-2034)
9.1.1 Global Pertussis Vaccine Sales Volume, Revenue Forecast and Growth Rate of Acellular Vaccines (2026-2034)
9.1.2 Global Pertussis Vaccine Sales Volume, Revenue Forecast and Growth Rate of Whole-cell Vaccines (2026-2034)
9.2 Global Pertussis Vaccine Market Forecast by End User (2026-2034)
9.2.1 Global Pertussis Vaccine Sales Volume, Revenue Forecast and Growth Rate of 12 Months Below (2026-2034)
9.2.2 Global Pertussis Vaccine Sales Volume, Revenue Forecast and Growth Rate of 12 Months Above (2026-2034)
10 Global Pertussis Vaccine Market Forecast by Geographic Region (2026-2034)
10.1 Global Pertussis Vaccine Sales Volume and Revenue Forecast by Geographic Region (2026-2034)
10.2 North America Pertussis Vaccine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.2.1 United States Pertussis Vaccine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.2.2 Canada Pertussis Vaccine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3 Europe Pertussis Vaccine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.1 Germany Pertussis Vaccine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.2 France Pertussis Vaccine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.3 United Kingdom Pertussis Vaccine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.4 Spain Pertussis Vaccine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.5 Russia Pertussis Vaccine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.6 Poland Pertussis Vaccine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4 Asia Pacific Pertussis Vaccine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.1 China Pertussis Vaccine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.2 Japan Pertussis Vaccine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.3 South Korea Pertussis Vaccine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.4 Southeast Asia Pertussis Vaccine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.5 India Pertussis Vaccine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.6 Australia Pertussis Vaccine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5 Latin America Pertussis Vaccine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5.1 Mexico Pertussis Vaccine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5.2 Brazil Pertussis Vaccine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6 Middle East and Africa Pertussis Vaccine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6.1 GCC Pertussis Vaccine Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6.2 South Africa Pertussis Vaccine Sales Volume, Revenue Forecast and Growth (2026-2034)
11 Appendix
11.1 Methodology
11.2 Research Data Source
11.2.1 Secondary Data
11.2.2 Primary Data
11.2.3 Market Size Estimation
11.2.4 Legal Disclaimer
